"PharmaPoint: Prostate Cancer - Current and Future Players" Published

2013-03-15 12:45:35 - Recently published research from GlobalData, "PharmaPoint: Prostate Cancer - Current and Future Players", is now available at Fast Market Research

GlobalData has released its pharma report, "PharmaPoint: Prostate Cancer - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Prostate Cancer Market. The report identifies and analyses the key companies shaping and driving the global Prostate Cancer market. The report provides insight into the competitive Prostate Cancer landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

* Investigation of current and future market competition for Prostate Cancer
* Competitor assessment
* Coverage of key market players and company profiles including business description, financial overview

and SWOT analysis.
* Strategic assessment of the Prostate Cancer sector through market impact analysis, future market scenario and company analysis

Full Report Details at
- www.fastmr.com/prod/553299_pharmapoint_prostate_cancer_current_a ..

Reasons to buy

* Gain a high level view of the trends shaping and driving the Prostate Cancer Market
* Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
* Create an effective counter-strategy to gain a competitive advantage against those currently in the market
* What's the next big thing in the global Prostate Cancer market landscape? Identify, understand and capitalize

Companies Mentioned in this Report: AstraZeneca, Abbott, Sanofi, Johnson & Johnson, Astellas Pharma

Report Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers - Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 AstraZeneca
4.3.2 Abbott
4.3.3 Sanofi
4.3.4 Johnson & Johnson
4.3.5 Astellas Pharma
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 Number of Prostate Cancer Patients Currently Seeking Treatment
5.4.2 Percent Drug-treated Patients
5.4.3 Percent Hormone Therapy-Treated Patients
5.4.4 Drugs Included in Each Therapeutic Class
5.4.5 Launch, Patent and Market Exclusivity Expiry Dates
5.4.6 General Pricing Assumptions
5.4.7 Individual Drug Assumptions
5.4.8 Generic Erosion
5.4.9 Pricing of Pipeline Agents
5.5 Physicians and Specialists Included in This Study
5.6 Survey of Prescribing Physicians
5.7 About the Authors
5.7.1 Authors
5.7.2 Global Head of Healthcare
5.8 About GlobalData
5.9 Contact Us
5.10 Disclaimer

List of Tables

1.1 List of Tables
Table 1: Global Sales Forecasts ($m) for Prostate Cancer, 2012-2022
Table 2: Global Prostate Cancer Market - Drivers and Barriers, 2012
Table 3: Key Companies in the Prostate Cancer, 2012
Table 4: AstraZeneca's Prostate Cancer Portfolio Assessment, 2012
Table 5: AstraZeneca's Prostate Cancer Portfolio SWOT Analysis, 2012
Table 6: Abbott's Prostate Cancer Portfolio Assessment, 2012
Table 7: Abbott's Prostate Cancer Portfolio SWOT Analysis, 2012
Table 8: Sanofi's Prostate Cancer Portfolio Assessment, 2012
Table 9: Sanofi's Prostate Cancer Portfolio SWOT Analysis, 2012
Table 10: J&J's Prostate Cancer Portfolio Assessment, 2012
Table 11: J&J's Prostate Cancer Portfolio SWOT Analysis, 2012
Table 12: Astellas Pharma's Prostate Cancer Portfolio Assessment, 2012
Table 13: Astellas Pharma's Prostate Cancer Portfolio SWOT Analysis, 2012
Table 14: Key Launch Dates
Table 15: Key Patent Expiries and Market Exclusivity Expiries
Table 16: Physicians Surveyed, By Country

List of Figures

1.2 List of Figures
Figure 1: Global Sales for Prostate Cancer by Region, 2012-2022
Figure 2: Company Portfolio Gap Analysis in Prostate Cancer, 2012-2022

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.